The European research consortium Joint Programs – Neurodegenerative Diseases (JPND) is using the Internet portal AmbulanzPartner.de for the ALS-CarE project. The ALS-CarE joint project aims to improve the care of patients with amyotrophic lateral sclerosis (ALS) in Europe.
Institutes and clinics at the universities in Dublin, London, Milan, Leuven, Munich and Berlin are involved in the project. Among other things, the research association is developing an internet-based treatment matrix for the care of people with ALS. The treatment matrix is intended to offer best practice treatment for ALS in Europe. The ALS-CarE research project will start at the beginning of 2014 and last three years.
On December 4, 2025, the ALS app will be presented at the"ALS App Europe Initiative…
Following our last newsletter on the introduction of the OPM classification in the ALS app,…
You can now submit your e-prescription with your health card via the ALS app at…
We are pleased to introduce an important new feature in the ALS app today: The…
The THC:CBD patient survey is a systematic survey of 130 patients with amyotrophic lateral sclerosis…
We are pleased to inform you that we have completely revised our medication module. With…